Robert Hoepner at Bern University Hospital - Research Interests, Publications & Academic Profile

Robert Hoepner

University Name

Switzerland

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Pakistani students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Neurology

70%

Multiple Sclerosis

50%

Neurological Disorder

40%

Neuroinflammation

40%

Autoimmunity

30%

Inflammatory Biology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Brain Age

Open Date: 2024-01-01

Close Date: 2026-01-01

Grant: Close

S1P receptor expression in people with MS

Open Date: 2023-01-01

Close Date: 2026-01-01

Grant: Close

Research on Quality of Life

Open Date:

Close Date:

Grant: Close

Congress Participation Support

Open Date:

Close Date:

Grant: Close

Steroid resistance in Multiple Sclerosis

Open Date:

Close Date:

Articles14

Sex‐ and age‐related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials

Article Link

Year:

2024

Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort

Article Link

Year:

2024

Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy

Article Link

Year:

2024

Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis

Article Link

Year:

2023

In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling

Article Link

Year:

2023

Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature

Article Link

Year:

2023

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

Article Link

Year:

2023

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy

Article Link

Year:

2023

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort

Article Link

Year:

2023

Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue?

Article Link

Year:

2022

Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature

Article Link

Year:

2022

Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study.

Article Link

Year:

2022

Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD).

Article Link

Year:

2022

Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS).

Article Link

Year:

2022

Collaborators15

Christian Rummel

SWITZERLAND

Caroline Pot

Associate Professor

Lausanne University Hospital

SWITZERLAND

Stefan Bittner

Johannes Gutenberg Universität Mainz

GERMANY

Christoph Friedli

SWITZERLAND

Anke Salmen

SWITZERLAND

Philippe C. Cattin

University of Basel

SWITZERLAND

Andrew Chan

Chief Physician, Deputy Head of Department, Head of Medical Division Neuro

University Hospital of Bern

SWITZERLAND

Marie Théaudin

University of Lausanne

SWITZERLAND

Mark Mühlau

GERMANY

Katharina Stegmayer

University of Bern

SWITZERLAND

Anna Lena Fisse

GERMANY

Daniel Surbek

Professor and Chairman

University of Bern

SWITZERLAND

Ludwig Kappos

Professor and Chair Neurology

University of Basel

SWITZERLAND

Alessandro Cagol

SWITZERLAND

Veronika Kana

University Hospital of Zurich

SWITZERLAND

How do Pakistani students reach out?

Meet Kite AI